DOI:
10.1055/s-00025479
Experimental and Clinical Endocrinology & Diabetes Reports
LinksClose Window
References
Zinman B, Wanner C, Lachin JM. et al.
Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes.
N Engl J Med 2015;
373: 2117-2128
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.